BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 19117363)

  • 1. Haplotype analysis of the PARK 11 gene, GIGYF2, in sporadic Parkinson's disease.
    Sutherland GT; Siebert GA; Newman JR; Silburn PA; Boyle RS; O'Sullivan JD; Mellick GD
    Mov Disord; 2009 Feb; 24(3):449-52. PubMed ID: 19117363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do polymorphisms in the familial Parkinsonism genes contribute to risk for sporadic Parkinson's disease?
    Sutherland GT; Halliday GM; Silburn PA; Mastaglia FL; Rowe DB; Boyle RS; O'Sullivan JD; Ly T; Wilton SD; Mellick GD
    Mov Disord; 2009 Apr; 24(6):833-8. PubMed ID: 19224617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the GIGYF2 gene in familial and sporadic Parkinson disease in the Spanish population.
    Samaranch L; Lorenzo E; Pastor MA; Riverol M; Luquin MR; Rodríguez-Oroz MC; Obeso JA; Pastor P
    Eur J Neurol; 2010 Feb; 17(2):321-5. PubMed ID: 19845746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in the GIGYF2 (TNRC15) gene at the PARK11 locus in familial Parkinson disease.
    Lautier C; Goldwurm S; Dürr A; Giovannone B; Tsiaras WG; Pezzoli G; Brice A; Smith RJ
    Am J Hum Genet; 2008 Apr; 82(4):822-33. PubMed ID: 18358451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follow-up study of the GIGYF2 gene in French families with Parkinson's disease.
    Lesage S; Condroyer C; Lohman E; Troiano A; Tison F; Viallet F; Damier P; Tranchant C; Vidhaillet M; Ouvrard-Hernandez AM; Dürr A; Brice A;
    Neurobiol Aging; 2010 Jun; 31(6):1069-71; discussion 1072-4. PubMed ID: 20004041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GIGYF2 mutations are not a frequent cause of familial Parkinson's disease.
    Di Fonzo A; Fabrizio E; Thomas A; Fincati E; Marconi R; Tinazzi M; Breedveld GJ; Simons EJ; Chien HF; Ferreira JJ; Horstink MW; Abbruzzese G; Borroni B; Cossu G; Dalla Libera A; Fabbrini G; Guidi M; De Mari M; Lopiano L; Martignoni E; Marini P; Onofrj M; Padovani A; Stocchi F; Toni V; Sampaio C; Barbosa ER; Meco G; ; Oostra BA; Bonifati V
    Parkinsonism Relat Disord; 2009 Nov; 15(9):703-5. PubMed ID: 19482505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GIGYF2 has no major role in Parkinson genetic etiology in a Belgian population.
    Meeus B; Nuytemans K; Crosiers D; Engelborghs S; Pals P; Pickut B; Peeters K; Mattheijssens M; Corsmit E; Cras P; De Deyn PP; Theuns J; Van Broeckhoven C
    Neurobiol Aging; 2011 Feb; 32(2):308-12. PubMed ID: 19321232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is GIGYF2 the defective gene at the PARK11 locus?
    Bonifati V
    Curr Neurol Neurosci Rep; 2009 May; 9(3):185-7. PubMed ID: 19348706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GIGYF2 Asn56Ser mutation is rare in Chinese Parkinson's disease patients.
    Zhang Y; Zheng L; Zhang T; Wang Y; Xiao Q; Fei QZ; Cui PJ; Cao L; Chen SD
    Neurosci Lett; 2009 Oct; 463(3):172-5. PubMed ID: 19638301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No evidence for pathogenic role of GIGYF2 mutation in Parkinson disease in Japanese patients.
    Li L; Funayama M; Tomiyama H; Li Y; Yoshino H; Sasaki R; Kokubo Y; Kuzuhara S; Mizuno Y; Hattori N
    Neurosci Lett; 2010 Aug; 479(3):245-8. PubMed ID: 20641165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational screening and zebrafish functional analysis of GIGYF2 as a Parkinson-disease gene.
    Guella I; Pistocchi A; Asselta R; Rimoldi V; Ghilardi A; Sironi F; Trotta L; Primignani P; Zini M; Zecchinelli A; Coviello D; Pezzoli G; Del Giacco L; Duga S; Goldwurm S
    Neurobiol Aging; 2011 Nov; 32(11):1994-2005. PubMed ID: 20060621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening PARK genes for mutations in early-onset Parkinson's disease patients from Queensland, Australia.
    Mellick GD; Siebert GA; Funayama M; Buchanan DD; Li Y; Imamichi Y; Yoshino H; Silburn PA; Hattori N
    Parkinsonism Relat Disord; 2009 Feb; 15(2):105-9. PubMed ID: 18486522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel GIGYF2 gene variants in patients with Parkinson's disease in Chinese population.
    Wang L; Guo JF; Zhang WW; Xu Q; Zuo X; Shi CH; Luo LZ; Liu J; Hu L; Hu YC; She L; Jiang H; Yan XX; Xia K; Pan Q; Tang BS
    Neurosci Lett; 2010 Apr; 473(2):131-5. PubMed ID: 20178831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational analysis of GIGYF2, ATP13A2 and GBA genes in Brazilian patients with early-onset Parkinson's disease.
    Dos Santos AV; Pestana CP; Diniz KR; Campos M; Abdalla-Carvalho CB; de Rosso AL; Pereira JS; Nicaretta DH; de Carvalho WL; Dos Santos JM; Santos-Rebouças CB; Pimentel MM
    Neurosci Lett; 2010 Nov; 485(2):121-4. PubMed ID: 20816920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common polymorphisms in dystonia-linked genes and susceptibility to the sporadic primary dystonias.
    Newman JR; Sutherland GT; Boyle RS; Limberg N; Blum S; O'Sullivan JD; Silburn PA; Mellick GD
    Parkinsonism Relat Disord; 2012 May; 18(4):351-7. PubMed ID: 22172551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-synonymous GIGYF2 variants in Parkinson's disease from two Asian populations.
    Tan EK; Lin CH; Tai CH; Tan LC; Chen ML; Li R; Lim HQ; Pavanni R; Yuen Y; Prakash KM; Zhao Y; Wu RM
    Hum Genet; 2009 Sep; 126(3):425-30. PubMed ID: 19449032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a risk haplotype of the alpha-synuclein gene in Japanese with sporadic Parkinson's disease.
    Kobayashi H; Ujike H; Hasegawa J; Yamamoto M; Kanzaki A; Sora I
    Mov Disord; 2006 Dec; 21(12):2157-64. PubMed ID: 17078049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterozygous parkin point mutations are as common in control subjects as in Parkinson's patients.
    Kay DM; Moran D; Moses L; Poorkaj P; Zabetian CP; Nutt J; Factor SA; Yu CE; Montimurro JS; Keefe RG; Schellenberg GD; Payami H
    Ann Neurol; 2007 Jan; 61(1):47-54. PubMed ID: 17187375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variation in GIGYF2 is not associated with Parkinson disease.
    Nichols WC; Kissell DK; Pankratz N; Pauciulo MW; Elsaesser VE; Clark KA; Halter CA; Rudolph A; Wojcieszek J; Pfeiffer RF; Foroud T;
    Neurology; 2009 Jun; 72(22):1886-92. PubMed ID: 19279319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TAU haplotype and the Saitohin Q7R gene polymorphism do not influence CSF Tau in Alzheimer's disease and are not associated with frontotemporal dementia or Parkinson's disease.
    Johansson A; Zetterberg H; Håkansson A; Nissbrandt H; Blennow K
    Neurodegener Dis; 2005; 2(1):28-35. PubMed ID: 16909000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.